Effect of magnesium supplementation on inflammatory factors and clinical outcomes of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia receiving a neutropenic diet: a randomized clinical trial.
Magnesium supplementation reduces inflammation markers and improves recovery in bone marrow transplant patients, suggesting a low-cost adjunct worth further study.
Magnesium supplementation significantly reduces inflammatory markers and improves clinical recovery in allo-HSCT patients in this double-blind RCT. Findings support investigating Mg as a low-cost, low-risk adjunct to reduce transplant-related inflammatory complications.
What the study was
- Study design
- Double-blind randomized controlled trial
- Population
- Acute leukemia patients undergoing allo-HSCT on neutropenic diet; n=45
- Sample size
- 45
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Scientific reports
Why it surfaced
Rigorous double-blind RCT of low-cost adjunct in allo-HSCT; significant inflammatory reduction; small n=45 limits generalizability.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.